The developed organoid models capture different and clinically relevant biological mechanisms of steatosis: while the FFA model captures primarily steatosis driven by a surplus of FFAs (approximating a Western diet), APOB−/− and MTTP−/− organoids develop steatosis through accumulation of lipids derived from DNL. The gene discussed is MT-TP; the disease is steatosis.